David Happel - President & CEO, Director at Sagimet Biosciences Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Issuer Symbol
SGMT on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Happel since 11 Jan 2025

Holdings reported by David Happel for Sagimet Biosciences Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Series A Common Stock 689,722 $2,193,315 $3.18 21 Jul 2025 Direct
Stock Option (Right to Buy) 472,000 06 Feb 2025 Direct Series A Common Stock

Transactions reported by David Happel for Sagimet Biosciences Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.